PDB Short entry for 2M6X HEADER MEMBRANE PROTEIN 12-APR-13 2M6X TITLE STRUCTURE OF THE P7 CHANNEL OF HEPATITIS C VIRUS, GENOTYPE 5A COMPND MOL_ID: 1; COMPND 2 MOLECULE: P7; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_COMMON: HCV; SOURCE 4 ORGANISM_TAXID: 356419; SOURCE 5 STRAIN: EUH1480; SOURCE 6 VARIANT: GENOTYPE 5A; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PMM-LR6 KEYWDS MEMBRANE PROTEIN, CATION CHANNEL EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR B.OUYANG,J.J.CHOU REVDAT 2 29-JAN-14 2M6X 1 JRNL REVDAT 1 12-JUN-13 2M6X 0 JRNL AUTH B.OUYANG,S.XIE,M.J.BERARDI,X.ZHAO,J.DEV,W.YU,B.SUN,J.J.CHOU JRNL TITL UNUSUAL ARCHITECTURE OF THE P7 CHANNEL FROM HEPATITIS C JRNL TITL 2 VIRUS JRNL REF NATURE V. 498 521 2013 JRNL REFN ISSN 0028-0836 JRNL PMID 23739335 JRNL DOI 10.1038/NATURE12283 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR_NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2M6X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-APR-13. REMARK 100 THE RCSB ID CODE IS RCSB103285. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.8 MM [U-100% 13C; U-100% 15N; REMARK 210 U-80% 2H] HCV P7 (MONOMER)-1, 200 REMARK 210 MM DPC-2, 25 MM MES-3, 95% H2O/5% REMARK 210 D2O; 0.8 MM [U-100% 13C; U-100% REMARK 210 15N] HCV P7 (MONOMER)-4, 200 MM REMARK 210 [U-2H] DPC-5, 25 MM MES-6, 95% REMARK 210 H2O/5% D2O; 0.8 MM [U-15% 13C] REMARK 210 HCV P7 (MONOMER)-7, 200 MM [U-2H] REMARK 210 DPC-8, 25 MM MES-9, 95% H2O/5% REMARK 210 D2O; 0.4 MM [U-15N; U-2H] HCV P7 REMARK 210 (MONOMER)-10, 0.4 MM [U-13C] HCV REMARK 210 P7 (MONOMER)-11, 200 MM [U-2H] REMARK 210 DPC-12, 25 MM MES-13, 95% H2O/5% REMARK 210 D2O; 0.2 MM [U-100% 13C; U-100% REMARK 210 15N; U-80% 2H] HCV P7 (MONOMER)- REMARK 210 14, 100 MM DPC-15, 25 MM MES-16, REMARK 210 4.5 % POLYACRYLAMIDE GEL-17, 95% REMARK 210 H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCA; 3D HN(CO)CA; 3D HN(CA) REMARK 210 CO; 3D HNCO; 3D HNCACB; 3D REMARK 210 HN(COCA)CB; 3D 1H-15N NOESY; 3D REMARK 210 1H-13C NOESY (MET); 3D 1H-13C REMARK 210 NOESY (DIAG SUPPRESS); 3D 1H-15N REMARK 210 NOESY (MIXED NOE); 2D 1H-15N HSQC REMARK 210 (28M CT); J-SCALED 15N TROSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, XEASY, TALOS, X-PLOR_NIH REMARK 210 METHOD USED : SIMULATED ANNEALING, MOLECULAR REMARK 210 DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 60 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 4 -46.86 -159.34 REMARK 500 1 HIS A 17 86.98 -52.54 REMARK 500 1 TYR A 42 -123.25 -148.17 REMARK 500 1 LEU A 45 -74.01 -95.44 REMARK 500 1 HIS A 59 152.68 58.41 REMARK 500 1 ARG A 60 75.57 -161.40 REMARK 500 1 LEU A 62 21.81 -76.59 REMARK 500 1 ALA B 2 -77.57 -158.85 REMARK 500 1 ASN B 4 -0.75 -156.32 REMARK 500 1 HIS B 17 -168.39 49.77 REMARK 500 1 PHE B 19 -96.20 -75.13 REMARK 500 1 VAL B 32 0.52 -65.05 REMARK 500 1 TYR B 42 116.18 176.85 REMARK 500 1 SER B 44 72.42 53.46 REMARK 500 1 LEU B 45 34.91 -159.55 REMARK 500 1 HIS B 59 160.09 55.15 REMARK 500 1 ARG B 60 113.68 -171.52 REMARK 500 1 LEU B 62 48.86 -71.73 REMARK 500 1 ALA C 2 -92.40 -54.91 REMARK 500 1 ASN C 4 -36.93 -151.10 REMARK 500 1 VAL C 32 -5.62 -58.53 REMARK 500 1 LEU C 45 23.02 -144.94 REMARK 500 1 HIS C 59 -66.31 64.70 REMARK 500 1 ARG C 60 116.27 59.82 REMARK 500 1 ALA D 2 -54.08 -171.20 REMARK 500 1 ASN D 4 40.40 -83.14 REMARK 500 1 VAL D 5 -68.39 -144.12 REMARK 500 1 HIS D 17 80.69 -55.01 REMARK 500 1 TYR D 42 -55.21 -163.63 REMARK 500 1 LEU D 43 81.66 58.91 REMARK 500 1 SER D 44 -177.39 -178.81 REMARK 500 1 HIS D 59 161.61 54.39 REMARK 500 1 ARG D 60 138.66 -174.11 REMARK 500 1 ASN E 4 -41.80 75.95 REMARK 500 1 HIS E 17 98.51 -53.40 REMARK 500 1 LEU E 43 -128.57 -59.94 REMARK 500 1 LEU E 45 48.59 -176.88 REMARK 500 1 ARG E 60 160.17 -46.95 REMARK 500 1 ASN F 4 -31.09 -158.10 REMARK 500 1 TYR F 42 119.39 -160.18 REMARK 500 1 SER F 44 -178.43 65.65 REMARK 500 1 TRP F 48 -42.62 -164.00 REMARK 500 1 HIS F 59 165.89 55.67 REMARK 500 2 ALA A 2 17.02 53.00 REMARK 500 2 ASN A 4 -49.88 -158.53 REMARK 500 2 HIS A 17 93.11 -56.17 REMARK 500 2 TYR A 42 -121.08 -133.45 REMARK 500 2 SER A 44 116.79 -39.16 REMARK 500 2 LEU A 45 -69.37 -93.32 REMARK 500 2 VAL A 47 -11.23 -153.03 REMARK 500 REMARK 500 THIS ENTRY HAS 752 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19162 RELATED DB: BMRB DBREF 2M6X A 1 63 UNP O39928 POLG_HCVEV 748 810 DBREF 2M6X B 1 63 UNP O39928 POLG_HCVEV 748 810 DBREF 2M6X C 1 63 UNP O39928 POLG_HCVEV 748 810 DBREF 2M6X D 1 63 UNP O39928 POLG_HCVEV 748 810 DBREF 2M6X E 1 63 UNP O39928 POLG_HCVEV 748 810 DBREF 2M6X F 1 63 UNP O39928 POLG_HCVEV 748 810 SEQADV 2M6X GLY A 1 UNP O39928 THR 748 ENGINEERED MUTATION SEQADV 2M6X ALA A 2 UNP O39928 CYS 749 ENGINEERED MUTATION SEQADV 2M6X SER A 12 UNP O39928 ALA 759 ENGINEERED MUTATION SEQADV 2M6X THR A 27 UNP O39928 CYS 774 ENGINEERED MUTATION SEQADV 2M6X SER A 44 UNP O39928 CYS 791 ENGINEERED MUTATION SEQADV 2M6X GLY B 1 UNP O39928 THR 748 ENGINEERED MUTATION SEQADV 2M6X ALA B 2 UNP O39928 CYS 749 ENGINEERED MUTATION SEQADV 2M6X SER B 12 UNP O39928 ALA 759 ENGINEERED MUTATION SEQADV 2M6X THR B 27 UNP O39928 CYS 774 ENGINEERED MUTATION SEQADV 2M6X SER B 44 UNP O39928 CYS 791 ENGINEERED MUTATION SEQADV 2M6X GLY C 1 UNP O39928 THR 748 ENGINEERED MUTATION SEQADV 2M6X ALA C 2 UNP O39928 CYS 749 ENGINEERED MUTATION SEQADV 2M6X SER C 12 UNP O39928 ALA 759 ENGINEERED MUTATION SEQADV 2M6X THR C 27 UNP O39928 CYS 774 ENGINEERED MUTATION SEQADV 2M6X SER C 44 UNP O39928 CYS 791 ENGINEERED MUTATION SEQADV 2M6X GLY D 1 UNP O39928 THR 748 ENGINEERED MUTATION SEQADV 2M6X ALA D 2 UNP O39928 CYS 749 ENGINEERED MUTATION SEQADV 2M6X SER D 12 UNP O39928 ALA 759 ENGINEERED MUTATION SEQADV 2M6X THR D 27 UNP O39928 CYS 774 ENGINEERED MUTATION SEQADV 2M6X SER D 44 UNP O39928 CYS 791 ENGINEERED MUTATION SEQADV 2M6X GLY E 1 UNP O39928 THR 748 ENGINEERED MUTATION SEQADV 2M6X ALA E 2 UNP O39928 CYS 749 ENGINEERED MUTATION SEQADV 2M6X SER E 12 UNP O39928 ALA 759 ENGINEERED MUTATION SEQADV 2M6X THR E 27 UNP O39928 CYS 774 ENGINEERED MUTATION SEQADV 2M6X SER E 44 UNP O39928 CYS 791 ENGINEERED MUTATION SEQADV 2M6X GLY F 1 UNP O39928 THR 748 ENGINEERED MUTATION SEQADV 2M6X ALA F 2 UNP O39928 CYS 749 ENGINEERED MUTATION SEQADV 2M6X SER F 12 UNP O39928 ALA 759 ENGINEERED MUTATION SEQADV 2M6X THR F 27 UNP O39928 CYS 774 ENGINEERED MUTATION SEQADV 2M6X SER F 44 UNP O39928 CYS 791 ENGINEERED MUTATION SEQRES 1 A 63 GLY ALA LYS ASN VAL ILE VAL LEU ASN ALA ALA SER ALA SEQRES 2 A 63 ALA GLY ASN HIS GLY PHE PHE TRP GLY LEU LEU VAL VAL SEQRES 3 A 63 THR LEU ALA TRP HIS VAL LYS GLY ARG LEU VAL PRO GLY SEQRES 4 A 63 ALA THR TYR LEU SER LEU GLY VAL TRP PRO LEU LEU LEU SEQRES 5 A 63 VAL ARG LEU LEU ARG PRO HIS ARG ALA LEU ALA SEQRES 1 B 63 GLY ALA LYS ASN VAL ILE VAL LEU ASN ALA ALA SER ALA SEQRES 2 B 63 ALA GLY ASN HIS GLY PHE PHE TRP GLY LEU LEU VAL VAL SEQRES 3 B 63 THR LEU ALA TRP HIS VAL LYS GLY ARG LEU VAL PRO GLY SEQRES 4 B 63 ALA THR TYR LEU SER LEU GLY VAL TRP PRO LEU LEU LEU SEQRES 5 B 63 VAL ARG LEU LEU ARG PRO HIS ARG ALA LEU ALA SEQRES 1 C 63 GLY ALA LYS ASN VAL ILE VAL LEU ASN ALA ALA SER ALA SEQRES 2 C 63 ALA GLY ASN HIS GLY PHE PHE TRP GLY LEU LEU VAL VAL SEQRES 3 C 63 THR LEU ALA TRP HIS VAL LYS GLY ARG LEU VAL PRO GLY SEQRES 4 C 63 ALA THR TYR LEU SER LEU GLY VAL TRP PRO LEU LEU LEU SEQRES 5 C 63 VAL ARG LEU LEU ARG PRO HIS ARG ALA LEU ALA SEQRES 1 D 63 GLY ALA LYS ASN VAL ILE VAL LEU ASN ALA ALA SER ALA SEQRES 2 D 63 ALA GLY ASN HIS GLY PHE PHE TRP GLY LEU LEU VAL VAL SEQRES 3 D 63 THR LEU ALA TRP HIS VAL LYS GLY ARG LEU VAL PRO GLY SEQRES 4 D 63 ALA THR TYR LEU SER LEU GLY VAL TRP PRO LEU LEU LEU SEQRES 5 D 63 VAL ARG LEU LEU ARG PRO HIS ARG ALA LEU ALA SEQRES 1 E 63 GLY ALA LYS ASN VAL ILE VAL LEU ASN ALA ALA SER ALA SEQRES 2 E 63 ALA GLY ASN HIS GLY PHE PHE TRP GLY LEU LEU VAL VAL SEQRES 3 E 63 THR LEU ALA TRP HIS VAL LYS GLY ARG LEU VAL PRO GLY SEQRES 4 E 63 ALA THR TYR LEU SER LEU GLY VAL TRP PRO LEU LEU LEU SEQRES 5 E 63 VAL ARG LEU LEU ARG PRO HIS ARG ALA LEU ALA SEQRES 1 F 63 GLY ALA LYS ASN VAL ILE VAL LEU ASN ALA ALA SER ALA SEQRES 2 F 63 ALA GLY ASN HIS GLY PHE PHE TRP GLY LEU LEU VAL VAL SEQRES 3 F 63 THR LEU ALA TRP HIS VAL LYS GLY ARG LEU VAL PRO GLY SEQRES 4 F 63 ALA THR TYR LEU SER LEU GLY VAL TRP PRO LEU LEU LEU SEQRES 5 F 63 VAL ARG LEU LEU ARG PRO HIS ARG ALA LEU ALA HELIX 1 1 GLY A 1 HIS A 17 1 17 HELIX 2 2 GLY A 18 THR A 41 1 24 HELIX 3 3 VAL A 47 ARG A 57 1 11 HELIX 4 4 VAL B 5 HIS B 17 1 13 HELIX 5 5 PHE B 19 THR B 41 1 23 HELIX 6 6 VAL B 47 ARG B 57 1 11 HELIX 7 7 GLY C 1 LYS C 3 5 3 HELIX 8 8 ASN C 4 HIS C 17 1 14 HELIX 9 9 GLY C 18 VAL C 32 1 15 HELIX 10 10 VAL C 32 THR C 41 1 10 HELIX 11 11 VAL C 47 ARG C 57 1 11 HELIX 12 12 ALA D 2 HIS D 17 1 16 HELIX 13 13 GLY D 18 THR D 41 1 24 HELIX 14 14 VAL D 47 ARG D 57 1 11 HELIX 15 15 ASN E 4 HIS E 17 1 14 HELIX 16 16 GLY E 18 THR E 41 1 24 HELIX 17 17 VAL E 47 ARG E 57 1 11 HELIX 18 18 ASN F 4 HIS F 17 1 14 HELIX 19 19 GLY F 18 THR F 41 1 24 HELIX 20 20 TRP F 48 ARG F 57 1 10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000